Dina Masi
2024
In 2024, Dina Masi earned a total compensation of $357.1K as Chief Financial Officer and Senior Vice President at Integrated Biopharma, a 8% increase compared to previous year.
Compensation breakdown
Bonus | $6,300 |
---|---|
Option Awards | $60,060 |
Salary | $280,000 |
Other | $10,721 |
Total | $357,081 |
Masi received $280K in salary, accounting for 78% of the total pay in 2024.
Masi also received $6.3K in bonus, $60.1K in option awards and $10.7K in other compensation.
Rankings
In 2024, Dina Masi's compensation ranked 116th out of 152 executives tracked by ExecPay. In other words, Masi earned more than 23.7% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 116 | 24th |
Manufacturing | 50 | 24th |
Chemicals And Allied Products | 18 | 31st |
Drugs | 18 | 31st |
Pharmaceutical Preparations | 16 | 30th |
Masi's colleagues
We found two more compensation records of executives working with Dina Masi at Integrated Biopharma in 2024.
News
Integrated Biopharma CFO Dina Masi's 2024 pay rises 8% to $357K
October 28, 2024
Integrated Biopharma CFO Dina Masi's 2023 pay rises 10% to $330K
October 27, 2023
Integrated Biopharma CFO Dina Masi's 2022 pay rises 12% to $300K
October 27, 2022
Integrated Biopharma CFO Dina Masi's 2021 pay rises 6% to $268K
October 27, 2021
Integrated Biopharma CFO Dina Masi's 2019 pay rises 4% to $251K
October 28, 2019